Beta-2 Microglobulin in Whole Unstimulated Saliva Can Effectively Distinguish Between Sjögren's Syndrome and Non-Autoimmune Sicca Symptoms.

Journal: Archives of rheumatology
Published Date: May 25, 2017

Abstract

OBJECTIVES: This study aims to describe salivary beta-2 microglobulin (sB2M) levels in our setting and to assess the performance of sB2M for the diagnosis of Sjögren's syndrome (SS).

Authors

  • Janett Riega-Torres
    Division of Rheumatology, University Hospital, Autonomous University of Nuevo León, Monterrey, Mexico.
  • Guillermo Delgado-García
    Department of Internal Medicine, University Hospital, Autonomous University of Nuevo León, Monterrey, Mexico.
  • Julio César Salas-Alanís
    Department of Basic Sciences, University of Monterrey, Monterrey, Mexico.
  • Cassandra Skinner-Taylor
    Division of Rheumatology, University Hospital, Autonomous University of Nuevo León, Monterrey, Mexico.
  • Lorena Pérez-Barbosa
    Division of Rheumatology, University Hospital, Autonomous University of Nuevo León, Monterrey, Mexico.
  • Mario Garza-Elizondo
    Division of Rheumatology, University Hospital, Autonomous University of Nuevo León, Monterrey, Mexico.
  • Celia Nohemí Sánchez-Domínguez
    Department of Biochemistry And Molecular Medicine, Faculty of Medicine, Autonomous University of Nuevo León, Monterrey, Mexico.
  • Luis Ángel Ceceñas-Falcón
    Division of Anatomic Pathology, University Hospital, Autonomous University of Nuevo León, Monterrey, Mexico.
  • Karim Mohamed-Noriega
    Department of Ophthalmology, University Hospital, Autonomous University of Nuevo León, Monterrey, Mexico.
  • Jesús Mohamed-Hamsho
    Department of Ophthalmology, University Hospital, Autonomous University of Nuevo León, Monterrey, Mexico.
  • David Vega-Morales
    Division of Rheumatology, University Hospital, Autonomous University of Nuevo León, Monterrey, Mexico.

Keywords

No keywords available for this article.

External Resources

Popular Topics
Recent Journals